Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: A randomised double-blind placebo-controlled clinical trial

Arthritis Research and Therapy

Volumn 11, Issue 6, 2009, Pages

  Jacquet, Alain ^a   Girodet, Pierre Olivier ^a,b,c   Pariente, Antoine ^a,b,c   Forest, Karelle ^a   Mallet, Laurent ^d   Moore, Nicholas ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d PHYTHEA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIRHEUMATIC AGENT; CELECOXIB; COPAREIN; DEXTROPROPOXYPHENE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DICLOFENAC; FISH OIL; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; MORPHINE SULFATE; NAPROXEN; OPIATE; PARACETAMOL; PHYTALGIC; PIROXICAM; PLACEBO; SULINDAC; TENOXICAM; TIAPROFENIC ACID; TRAMADOL; UNCLASSIFIED DRUG; URTICA DIOICA EXTRACT; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANADA; COMMON COLD; CYSTITIS; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; ERUCTATION; FALLING; FEMALE; HIP OSTEOARTHRITIS; HUMAN; ISCHIALGIA; KNEE OSTEOARTHRITIS; LOW BACK PAIN; LYMPHANGITIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; OUTCOME ASSESSMENT; PAIN; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RIGIDITY; SIDE EFFECT; TOOTH PAIN; TREATMENT DURATION; URTICA DIOICA; VOMITING; WESTERN ONTARIO MCMASTER UNIVERSITY OSTEO ARTHRITIS INDEX FUNCTION SCALE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; OSTEOARTHRITIS; PHYTOTHERAPY;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FISH OILS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN; PHYTOTHERAPY; PLACEBOS; URTICA DIOICA; VITAMIN E;

EID: 77952506057     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2891     Document Type: Article

References (38)

1. Bjordal JM, Klovning A, Ljunggren AE, Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur J Pain 2007, 11:125-138. 10.1016/j.ejpain.2006.02.013, 16682240.
2. Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med 2006, 354:841-848. 10.1056/NEJMcp051726, 16495396.
3. Moore N. Place of OTC analgesics and NSAIDs in osteoarthritis. Inflammopharmacology 2003, 11:355-362. 10.1163/156856003322699537, 15035789.
4. Moore N. Diclofenac potassium 12.5 mg tablets for mild to moderate pain and Fever: a review of its pharmacology, clinical efficacy and safety. Clin Drug Investig 2007, 27:163-195. 10.2165/00044011-200727030-00002, 17305413.
5. Moore N, Charlesworth A, Van Ganse E, LeParc JM, Jones JK, Wall R, Schneid H, Verriere F. Risk factors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiol Drug Saf 2003, 12:601-610. 10.1002/pds.842, 14558184.
6. Moore N, Van Ganse E, Le Parc J, Wall R, Schneid H, Farhan M, Verrière F, Pelen F. The PAIN study: Paracetamol, Aspirin and Ibuprofen New tolerability study. A large scale, randomized clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Invest 1999, 18:89-98.
7. Schaffer D, Florin T, Eagle C, Marschner I, Singh G, Grobler M, Fenn C, Schou M, Curnow KM. Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review. Med J Aust 2006, 185:501-506.
8. Singh G, Wu O, Langhorne P, Madhok R. Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther 2006, 8:R153. 10.1186/ar2047, 1779447, 16995929.
9. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999, 340:1888-1899. 10.1056/NEJM199906173402407, 10369853.
10. Bruyere O, Reginster JY. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging 2007, 24:573-580. 10.2165/00002512-200724070-00005, 17658908.
11. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006, 354:795-808. 10.1056/NEJMoa052771, 16495392.
12. Mazieres B, Hucher M, Zaim M, Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 2007, 66:639-645. 10.1136/ard.2006.059899, 17204566.
13. Hochberg MC, Dougados M. Pharmacological therapy of osteoarthritis. Best Pract Res Clin Rheumatol 2001, 15:583-593. 10.1053/berh.2001.0175, 11567541.
14. Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, Dieppe PA, Juni P. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007, 146:580-590.
15. Lagnaoui R, Baumevielle M, Begaud B, Pouyanne P, Maurice G, Depont F, Moore N. Less use of NSAIDs in long-term than in recent chondroitin sulphate users in osteoarthritis: a pharmacy-based observational study in France. Therapie 2006, 61:341-346.
16. Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 2006, 8:R127. 10.1186/ar2016, 1779427, 16859534.
17. Clayton JJ. Nutraceuticals in the management of osteoarthritis. Orthopedics 2007, 30:624-629. quiz 630-621.
18. Darlington LG, Stone TW. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr 2001, 85:251-269. 10.1079/BJN2000239, 11299072.
19. Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999, 25:379-395. 10.1016/S0889-857X(05)70074-0, 10356424.
20. Hauselmann HJ. Nutripharmaceuticals for osteoarthritis. Best Pract Res Clin Rheumatol 2001, 15:595-607. 10.1053/berh.2001.0176, 11567542.
21. Zochling J, March L, Lapsley H, Cross M, Tribe K, Brooks P. Use of complementary medicines for osteoarthritis--a prospective study. Ann Rheum Dis 2004, 63:549-554. 10.1136/ard.2003.010637, 1754991, 15082486.
22. Rayman MP, Pattison DJ. Dietary manipulation in musculoskeletal conditions. Best Pract Res Clin Rheumatol 2008, 22:535-561. 10.1016/j.berh.2007.12.010, 18519104.
23. Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm 1986, 21:233-234.
24. Moore N, Diris H, Martin K, Viale R, Fourrier A, Moride Y, Begaud B. NSAID use profiles derived from reimbursement data in France. Therapie 2004, 59:541-546.
25. Roggeri D, Saramin C, Terrazzani G, Zusso M, Giusti P, Chinellato A. Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy. Pharmacol Res 2007, 56:329-334. 10.1016/j.phrs.2007.08.001, 17851088.
26. Setty AR, Sigal LH. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 2005, 34:773-784. 10.1016/j.semarthrit.2005.01.011, 15942912.
27. Ernst E. Complementary and alternative medicine in rheumatology. Baillieres Best Pract Res Clin Rheumatol 2000, 14:731-749. 10.1053/berh.2000.0110, 11092799.
28. Curtis CL, Rees SG, Cramp J, Flannery CR, Hughes CE, Little CB, Williams R, Wilson C, Dent CM, Harwood JL, Caterson B. Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc 2002, 61:381-389. 10.1079/PNS2002174, 12230798.
29. Stammers T, Sibbald B, Freeling P. Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general practice. Ann Rheum Dis 1992, 51:128-129. 10.1136/ard.51.1.128, 1004637, 1540019.
30. Whitehouse MW, Rainsford KD, Taylor RM, Vernon-Roberts B. Zinc monoglycerolate: a slow-release source of zinc with anti-arthritic activity in rats. Agents Actions 1990, 31:47-58. 10.1007/BF02003221, 2285022.
31. Zoli A, Altomonte L, Caricchio R, Galossi A, Mirone L, Ruffini MP, Magaro M. Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. Clin Rheumatol 1998, 17:378-382. 10.1007/BF01450895, 9805181.
32. Chrubasik JE, Roufogalis BD, Wagner H, Chrubasik SA. A comprehensive review on nettle effect and efficacy profiles, Part I: herba urticae. Phytomedicine 2007, 14:423-435. 10.1016/j.phymed.2007.03.004, 17493795.
33. Randall C, Randall H, Dobbs F, Hutton C, Sanders H. Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med 2000, 93:305-309. 1298033, 10911825.
34. [General practice study with nettle extract. Arthrosis patient need fewer non-steroidal anti-inflammatory drugs]. MMW Fortschr Med 2002, 144:52. [Article in German].
35. Kurz B, Jost B, Schunke M. Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of antioxidative enzymes in the knee joint of STR/1N mice. Osteoarthritis Cartilage 2002, 10:119-126. 10.1053/joca.2001.0489, 11869071.
36. Canter PH, Wider B, Ernst E. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology (Oxford) 2007, 46:1223-1233. 10.1093/rheumatology/kem116, 17522095.
37. Hill J, Bird HA. Failure of selenium-ace to improve osteoarthritis. Br J Rheumatol 1990, 29:211-213. 10.1093/rheumatology/29.3.211, 2192771.
38. Phythea. , http://www.phythea.net